Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study

BackgroundGuidelines recommend lipid-lowering therapy (LLT) after an atherosclerotic cardiovascular disease (ASCVD) event. This study investigated real-world LLT initiation rate and its effect on total mortality in the Lombardy region.MethodsIndividuals aged ≥40 with an ASCVD event between January a...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Frontiers in Pharmacology
المؤلفون الرئيسيون:	Manuela Casula, Stefano Scotti, Federica Galimberti, Giacomo Matteo Bruno, Giorgio Lorenzo Colombo, Asiiat Alieva, Sining Xie, Alberico Luigi Catapano, Elena Olmastroni
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2025-09-01
الموضوعات:	lipid-lowering therapies atherosclerotic cardiovascular event secondary prevention guidelines compliance treatment outcomes
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1588376/full